Skip to main content
. 2017 Dec 7;9(1):668–679. doi: 10.18632/oncotarget.23089

Figure 6. C-MYC and BCL-2 were the target genes of YAP-TEAD1 transcriptional active complex.

Figure 6

(A, B) The changes of mRNA levels of C-MYC and BCL-2 after YAP knockdown or overexpression. (C, D) Western blot analysis of the expression of C-MYC and BCL-2 and other cell cycle-related and apoptosis-related proteins, such as Cyclin D1, BAX, Caspase7. GAPDH was used as a loading control. *p < 0.05.